Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Talin: A potential drug target for Cancer therapy.

Malla RR, Vempati RK.

Curr Drug Metab. 2020 Feb 13. doi: 10.2174/1389200221666200214114018. [Epub ahead of print]

PMID:
32056520
2.

Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer.

Deepak KGK, Vempati R, Nagaraju GP, Dasari VR, S N, Rao DN, Malla RR.

Pharmacol Res. 2020 Feb 9:104683. doi: 10.1016/j.phrs.2020.104683. [Epub ahead of print] Review.

PMID:
32050092
3.

Complete Genome Sequence of Myophage Ec_Makalu_002, Which Infects Uropathogenic Escherichia coli.

Dhungana G, Malla R, Rajaure M, Adhya S.

Microbiol Resour Announc. 2020 Jan 30;9(5). pii: e01530-19. doi: 10.1128/MRA.01530-19.

4.

Prognostic role of Hedgehog GLI1 signaling pathway in aggressive and metastatic breast cancers.

Rokkam P, Gugalavath S, Deepak Kgk, Vempati RK, Malla RR.

Curr Drug Metab. 2020 Jan 22. doi: 10.2174/1389200221666200122120625. [Epub ahead of print]

PMID:
31969097
5.

Current Perspectives of Exosomes as Therapeutic Targets and Drug Delivery Vehicles for Pancreatic Cancer.

Srinivas L, S D, Kgk D, Malla RR.

Crit Rev Oncog. 2019;24(2):179-190. doi: 10.1615/CritRevOncog.2019031202.

PMID:
31679212
6.

Cytogenetic, Molecular, and Translational Applications in Pancreatic Ductal Adenocarcinoma: Current Evidence and Future Concepts.

Malla RR, Kumari S.

Crit Rev Oncog. 2019;24(2):119-132. doi: 10.1615/CritRevOncog.2019030929.

PMID:
31679207
7.

Marine natural compound cyclo(L-leucyl-L-prolyl) peptide inhibits migration of triple negative breast cancer cells by disrupting interaction of CD151 and EGFR signaling.

Kgk D, Kumari S, G S, Malla RR.

Chem Biol Interact. 2020 Jan 5;315:108872. doi: 10.1016/j.cbi.2019.108872. Epub 2019 Oct 24.

PMID:
31669320
8.

Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for Diagnosis and Treatment of Breast, Ovarian and Cervical Cancers.

Talluri S, Malla RR.

Curr Drug Metab. 2019;20(12):942-945. doi: 10.2174/1389200220666191016124958.

PMID:
31622217
9.

ShRNA-mediated matrix metalloproteinase-2 gene silencing protects normal cells and sensitizes cancer cells against ionizing-radiation induced damage.

Shailender G, Patanla K, Malla RR.

J Cell Biochem. 2020 Feb;121(2):1332-1352. doi: 10.1002/jcb.29369. Epub 2019 Sep 6.

PMID:
31489968
10.

Recent advances in metabolomics of triple negative breast cancer.

Kumari S, Malla RR.

Breast J. 2019 Sep 6. doi: 10.1111/tbj.13524. [Epub ahead of print]

PMID:
31489744
11.

A Review on the Effect of Plant Extract on Mesenchymal Stem Cell Proliferation and Differentiation.

Saud B, Malla R, Shrestha K.

Stem Cells Int. 2019 Jul 24;2019:7513404. doi: 10.1155/2019/7513404. eCollection 2019. Review.

12.

Effect of MMP-2 gene silencing on radiation-induced DNA damage in human normal dermal fibroblasts and breast cancer cells.

Shailender G, Kumari S, Kiranmayi P, Malla RR.

Genes Environ. 2019 Jul 22;41:16. doi: 10.1186/s41021-019-0131-x. eCollection 2019.

13.

Horizons of nanotechnology applications in female specific cancers.

Rajitha B, Malla RR, Vadde R, Kasa P, Prasad GLV, Farran B, Kumari S, Pavitra E, Kamal MA, Raju GSR, Peela S, Nagaraju GP.

Semin Cancer Biol. 2019 Jul 10. pii: S1044-579X(19)30090-2. doi: 10.1016/j.semcancer.2019.07.005. [Epub ahead of print] Review.

PMID:
31301361
14.

Synergistic enhancement of apoptosis by coralyne and paclitaxel in combination on MDA-MB-231 a triple-negative breast cancer cell line.

Kumari S, Mohan MG, Shailender G, Badana AK, Malla RR.

J Cell Biochem. 2019 Oct;120(10):18104-18116. doi: 10.1002/jcb.29114. Epub 2019 Jun 6.

PMID:
31172606
15.

A perspective on the diagnostics, prognostics, and therapeutics of microRNAs of triple-negative breast cancer.

Malla RR, Kumari S, Gavara MM, Badana AK, Gugalavath S, Kumar DKG, Rokkam P.

Biophys Rev. 2019 Apr;11(2):227-234. doi: 10.1007/s12551-019-00503-8. Epub 2019 Feb 22. Review.

16.

A comparative anticancer study on procyanidin C1 against receptor positive and receptor negative breast cancer.

Koteswari LL, Kumari S, Kumar AB, Malla RR.

Nat Prod Res. 2019 Jan 8:1-8. doi: 10.1080/14786419.2018.1557173. [Epub ahead of print]

PMID:
30618284
17.

Door-to-balloon time and the determining factors in a tertiary cardiac center in Nepal.

Dhungel S, Malla R, Adhikari C, Maskey A, Rajbhandari R, Sharma R, Nepal H, Rauniyar B, Yadav D, Limbu D, Gautam M, Adhikari A, Dhungel S, Upadhyay H.

Indian Heart J. 2018 Dec;70 Suppl 3:S309-S312. doi: 10.1016/j.ihj.2018.07.011. Epub 2018 Aug 27.

18.

Percutaneous transluminal mitral valvuloplasty in post Mitral valve repair and Aortic valve replacement patient.

Mani Adhikari C, Malla R, Koirala R, Prajapati D, Gautam N.

Egypt Heart J. 2018 Jun;70(2):57-58. doi: 10.1016/j.ehj.2017.11.001. Epub 2017 Nov 29.

19.

Phase diagram for the Harper model of the honeycomb lattice.

Jose G, Malla R, Srinivasan V, Sharma A, Gangadharaiah S.

J Phys Condens Matter. 2018 Sep 26;30(38):385603. doi: 10.1088/1361-648X/aada3d. Epub 2018 Aug 14.

PMID:
30106380
20.

Emergence of dengue in Nepal.

Gupta BP, Lamsal M, Chaulagain S, Rauniyar R, Malla R, Shrestha S, Kurmi R, Das Manandhar K.

Virusdisease. 2018 Jun;29(2):129-133. doi: 10.1007/s13337-018-0439-3. Epub 2018 Feb 17. Review.

21.

C-glycosyl flavone from Urginea indica inhibits proliferation & angiogenesis & induces apoptosis via cyclin-dependent kinase 6 in human breast, hepatic & colon cancer cell lines.

Bevara GB, Naveen Kumar AD, Koteshwaramma KL, Badana A, Kumari S, Malla RR.

Indian J Med Res. 2018 Feb;147(2):158-168. doi: 10.4103/ijmr.IJMR_51_16.

22.

Fibromuscular dysplasia in an adult male as a cause of renal artery stenosis and secondary hypertension treated with renal artery stenting.

Bishal KC, Malla R, Adhikari CM, Rauniyar B, Limbu D.

Egypt Heart J. 2017 Mar;69(1):81-84. doi: 10.1016/j.ehj.2016.09.004. Epub 2016 Oct 4.

23.

Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers.

Malla RR, Pandrangi S, Kumari S, Gavara MM, Badana AK.

Asia Pac J Clin Oncol. 2018 Dec;14(6):383-391. doi: 10.1111/ajco.12869. Epub 2018 Mar 25. Review.

PMID:
29575602
24.

Prehospital Events in ST- Elevation Myocardial Infarction Undergoing Primary Angioplasty.

Dhungel S, Malla R, Adhikari C, Maskey A, Rajbhandari R, Sharma R, Sharma D, Man Bhadhur KC, Adhikari A, Rauniyar B, Limbu D, Gautam M.

JNMA J Nepal Med Assoc. 2017 Oct-Dec;56(208):421-5.

PMID:
29453473
25.

Reactive Oxygen Species: A Key Constituent in Cancer Survival.

Kumari S, Badana AK, G MM, G S, Malla R.

Biomark Insights. 2018 Feb 6;13:1177271918755391. doi: 10.1177/1177271918755391. eCollection 2018. Review.

26.

Erythropoietin monotherapy in perinatal asphyxia with moderate to severe encephalopathy: a randomized placebo-controlled trial.

Malla RR, Bhat MA.

J Perinatol. 2018 Mar;38(3):294. doi: 10.1038/s41372-018-0054-6. Epub 2018 Feb 9. No abstract available.

PMID:
29426852
27.

Lipid rafts disruption induces apoptosis by attenuating expression of LRP6 and survivin in triple negative breast cancer.

Badana AK, Chintala M, Gavara MM, Naik S, Kumari S, Kappala VR, Iska BR, Malla RR.

Biomed Pharmacother. 2018 Jan;97:359-368. doi: 10.1016/j.biopha.2017.10.045. Epub 2017 Nov 6.

PMID:
29091885
28.

Anthocyanins: Multi-Target Agents for Prevention and Therapy of Chronic Diseases.

Putta S, Yarla NS, Peluso I, Tiwari DK, Reddy GV, Giri PV, Kumar N, Malla R, Rachel V, Bramhachari PV, Reddy D RS, Bade R, Mannarapu M, Barreto GE, Lu DY, Tarasov VV, Chubarev VN, Ribeiro FF, Scotti L, Scotti MT, Kamal MA, Ashraf GM, Aliev G, Perry G, Sarker SD, Rao CV, Bishayee A.

Curr Pharm Des. 2017;23(41):6321-6346. doi: 10.2174/1381612823666170519151801. Review.

PMID:
28741457
29.

Synergistic effects of coralyne and paclitaxel on cell migration and proliferation of breast cancer cells lines.

Kumari S, Badana AK, Mohan GM, Shailender Naik G, Malla R.

Biomed Pharmacother. 2017 Jul;91:436-445. doi: 10.1016/j.biopha.2017.04.027. Epub 2017 May 2.

PMID:
28475922
30.

Erythropoietin monotherapy in perinatal asphyxia with moderate to severe encephalopathy: a randomized placebo-controlled trial.

Malla RR, Asimi R, Teli MA, Shaheen F, Bhat MA.

J Perinatol. 2017 May;37(5):596-601. doi: 10.1038/jp.2017.17. Epub 2017 Mar 9.

PMID:
28277490
31.

Maternal hyperhomocysteinemia and congenital heart defects: A prospective case control study in Indian population.

Malik RA, Lone MR, Ahmed A, Koul KA, Malla RR.

Indian Heart J. 2017 Jan - Feb;69(1):17-19. doi: 10.1016/j.ihj.2016.07.014. Epub 2016 Aug 20.

32.

Lipid Raft Integrity Is Required for Survival of Triple Negative Breast Cancer Cells.

Badana A, Chintala M, Varikuti G, Pudi N, Kumari S, Kappala VR, Malla RR.

J Breast Cancer. 2016 Dec;19(4):372-384. doi: 10.4048/jbc.2016.19.4.372. Epub 2016 Dec 23.

33.

C-glycosyl Flavone from Urginea indica Inhibits Growth and Dissemination of Ehrlich Ascites Carcinoma Cells in Mice.

Bevara GB, Kumar ADN, Koteswramma K L, Badana AK, Kumari S, Yarla NS, Malla RR.

Anticancer Agents Med Chem. 2017;17(9):1256-1266. doi: 10.2174/1871520617666170103101844.

PMID:
28044935
34.

Percutaneous transvenous mitral commissurotomy in mitral stenosis and left atrial appendage clot patients in special conditions: Hospital-based study.

Rajbhandari R, Malla R, Maskey A, Bhatta Y, Limbu Y, Sharma R, Singh S, Adhikari C, Mishra S.

Indian Heart J. 2016 Nov - Dec;68(6):788-791. doi: 10.1016/j.ihj.2016.04.020. Epub 2016 May 21.

35.

Isolation and Physicochemical Characterization of Laccase from Ganoderma lucidum-CDBT1 Isolated from Its Native Habitat in Nepal.

Shrestha P, Joshi B, Joshi J, Malla R, Sreerama L.

Biomed Res Int. 2016;2016:3238909. Epub 2016 Oct 16.

36.

Multi-targeting Andrographolide and its Natural Analogs as Potential Therapeutic Agents.

Kishore V, Yarla NS, Bishayee A, Putta S, Malla R, Neelapu NR, Challa S, Das S, Shiralgi Y, Hegde G, Dhananjaya BL.

Curr Top Med Chem. 2017;17(8):845-857. doi: 10.2174/1568026616666160927150452. Review.

PMID:
27697058
37.
38.

Pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinolines: Novel compounds that reverse ABCG2-mediated resistance in cancer cells.

Karthikeyan C, Malla R, Ashby CR Jr, Amawi H, Abbott KL, Moore J, Chen J, Balch C, Lee C, Flannery PC, Trivedi P, Faridi JS, Pondugula SR, Tiwari AK.

Cancer Lett. 2016 Jun 28;376(1):118-26. doi: 10.1016/j.canlet.2016.03.030. Epub 2016 Mar 21.

PMID:
27012188
39.

Re-emergence of dengue virus serotype 2 strains in the 2013 outbreak in Nepal.

Gupta BP, Singh S, Kurmi R, Malla R, Sreekumar E, Manandhar KD.

Indian J Med Res. 2015 Dec;142 Suppl:S1-6. doi: 10.4103/0971-5916.176564.

40.

Percutaneous transvenous mitral commissurotomy in juvenile mitral stenosis.

Adhikari CM, Malla R, Rajbhandari R, Shakya U, Sharma P, Shrestha N, Kc B, Limbu D, Kc MB.

Cardiovasc Diagn Ther. 2016 Feb;6(1):20-4. doi: 10.3978/j.issn.2223-3652.2015.12.07.

41.

Targeting Ribonucleotide Reductase M2 and NF-κB Activation with Didox to Circumvent Tamoxifen Resistance in Breast Cancer.

Shah KN, Wilson EA, Malla R, Elford HL, Faridi JS.

Mol Cancer Ther. 2015 Nov;14(11):2411-21. doi: 10.1158/1535-7163.MCT-14-0689. Epub 2015 Sep 2.

42.

New Insight on the Role of Plasminogen Receptor in Cancer Progression.

Kumari S, Malla R.

Cancer Growth Metastasis. 2015 Jul 29;8:35-42. doi: 10.4137/CGM.S27335. eCollection 2015. Review.

43.

Proline-rich AKT substrate of 40-kDa (PRAS40) in the pathophysiology of cancer.

Malla R, Ashby CR Jr, Narayanan NK, Narayanan B, Faridi JS, Tiwari AK.

Biochem Biophys Res Commun. 2015 Jul 31;463(3):161-6. doi: 10.1016/j.bbrc.2015.05.041. Epub 2015 May 20. Review.

PMID:
26003731
44.

Genetic ablation of PRAS40 improves glucose homeostasis via linking the AKT and mTOR pathways.

Malla R, Wang Y, Chan WK, Tiwari AK, Faridi JS.

Biochem Pharmacol. 2015 Jul 1;96(1):65-75. doi: 10.1016/j.bcp.2015.04.016. Epub 2015 Apr 27.

PMID:
25931147
45.

CD151-A Striking Marker for Cancer Therapy.

Kumari S, Devi G 5th, Badana A, Dasari VR, Malla RR.

Biomark Cancer. 2015 Mar 22;7:7-11. doi: 10.4137/BIC.S21847. eCollection 2015. Review.

46.

Risk of diarrhoea from shallow groundwater contaminated with enteropathogens in the Kathmandu Valley, Nepal.

Shrestha S, Haramoto E, Malla R, Nishida K.

J Water Health. 2015 Mar;13(1):259-69. doi: 10.2166/wh.2014.036.

PMID:
25719484
47.

Rat hormone sensitive lipase inhibition by cyclipostins and their analogs.

Vasilieva E, Dutta S, Malla RK, Martin BP, Spilling CD, Dupureur CM.

Bioorg Med Chem. 2015 Mar 1;23(5):944-52. doi: 10.1016/j.bmc.2015.01.028. Epub 2015 Jan 22.

48.

Synthesis of non-racemic α-hydroxyphosphonates via asymmetric phospho-aldol reaction.

Spilling CD, Malla RK.

Top Curr Chem. 2015;361:83-136. doi: 10.1007/128_2014_583. Review.

PMID:
25467537
49.

Relay cross metathesis reactions of vinylphosphonates.

Malla RK, Ridenour JN, Spilling CD.

Beilstein J Org Chem. 2014 Aug 19;10:1933-41. doi: 10.3762/bjoc.10.201. eCollection 2014.

50.

High-throughput DNA microarray detection of pathogenic bacteria in shallow well groundwater in the Kathmandu Valley, Nepal.

Inoue D, Hinoura T, Suzuki N, Pang J, Malla R, Shrestha S, Chapagain SK, Matsuzawa H, Nakamura T, Tanaka Y, Ike M, Nishida K, Sei K.

Curr Microbiol. 2015 Jan;70(1):43-50. doi: 10.1007/s00284-014-0681-x. Epub 2014 Aug 22.

PMID:
25146188

Supplemental Content

Support Center